BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients – A study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD... von Ruscito, I, Dimitrova, D, Vasconcelos, I, Gellhaus, K, Schwachula, T, Bellati, F, Zeillinger, R, Benedetti-Panici, P, Vergote, I, Mahner, S, Cacsire-Tong, D, Concin, N, Darb-Esfahani, S, Lambrechts, S, Sehouli, J, Olek, S, Braicu, E.I

Volltext

Influence of migrant background on patient preference and expectations in breast and gynecological malignancies (NOGGO-expression V study): results of a prospective multicentre stu... von Dimitrova, D., Naghavi, B., Richter, R., Nasser, S., Chekerov, R., Braicu, E., David, M., Blohmer, J., Inci, G., Torsten, U., Oskay-Oezcelik, G., Blau, Fersis, N., Holzgreve, A., Keil, E., Keller, M., Keilholz, U., Sehouli, J.

Volltext

Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers von Braicu, E-I, Sehouli, J, Richter, R, Pietzner, K, Denkert, C, Fotopoulou, C

Volltext

Adult granulosa cell tumors of the ovary: Tumor dissemination pattern at primary and recurrent situation, surgical outcome von Fotopoulou, C, Savvatis, K, Braicu, E-I, Brink-Spalink, V, Darb-Esfahani, S, Lichtenegger, W, Sehouli, J

Volltext

Quaternary cytoreductive surgery in ovarian cancer: does surgical effort still matter? von Fotopoulou, C, Savvatis, K, Kosian, P, Braicu, I E, Papanikolaou, G, Pietzner, K, Schmidt, S-C, Sehouli, J

Volltext

Can complete tumor resection be predicted in advanced primary epithelial ovarian cancer? A systematic evaluation of 360 consecutive patients von Fotopoulou, C, Richter, R, Braicu, E.I, Schmidt, S.-C, Lichtenegger, W, Sehouli, J

Volltext

Feasibility of Surgery After Systemic Treatment with the Humanized Recombinant Antibody Bevacizumab in Heavily Pretreated Patients with Advanced Epithelial Ovarian Cancer von Sehouli, Jalid, Papanikolaou, G., Braicu, E.-I., Pietzner, K., Neuhaus, P., Fotopoulou, C.

Volltext

Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: An analysis of five prospective phase II/III trials of NOGGO metadata base von Canaz, E, Grabowski, J.P, Richter, R, Braicu, E.I, Chekerov, R, Sehouli, J

Volltext

Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer von Vergote, I., Van Nieuwenhuysen, E., Casado, A., Laenen, A., Lorusso, D., Braicu, E.I., Guerra-Alia, E., Zola, P., Wimberger, P., Debruyne, P.R., Falcó, E., Ferrero, A., Muallem, M.Z., Kerger, J., García-Martinez, E., Pignata, S., Sehouli, J., Van Gorp, T., Gennigens, C., Rubio, M.J.

Volltext

Statistical controversies in clinical research: the importance of importance von Gleiss, A., Zeillinger, R., Braicu, E.I., Trillsch, F., Vergote, I., Schemper, M.

Volltext

Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort von Zang, R Y, Harter, P, Chi, D S, Sehouli, J, Jiang, R, Tropé, C G, Ayhan, A, Cormio, G, Xing, Y, Wollschlaeger, K M, Braicu, E I, Rabbitt, C A, Oksefjell, H, Tian, W J, Fotopoulou, C, Pfisterer, J, du Bois, A, Berek, J S

Volltext

Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study von Braicu, E I, Fotopoulou, C, Van Gorp, T, Richter, R, Chekerov, R, Hall, C, Butz, H, Castillo-Tong, D Cacsire, Mahner, S, Zeillinger, R, Concin, N, Vergote, I, Sehouli, J

Volltext

Polymorphism of the IL-8 gene and the risk of ovarian cancer von Koensgen, D., Bruennert, D., Ungureanu, S., Sofroni, D., Braicu, E.I., Sehouli, J., Sümnig, A., Delogu, S., Zygmunt, M., Goyal, P., Evert, M., Olek, S., Biebler, K.E., Mustea, A.

Volltext

Preoperative c-reactive protein and thrombocyte count as potential markers for longterm survival in ovarian cancer von Braicu, E.I., Sehouli, J., Richter, R., Vergote, I.B., Concin, N., van Nieuwenhuysen, E., Achimas, P., Berger, A., Fetica, B., Mahner, S., Glajzer, J., Papadia, A., Woelber, L., Gasparri, M.L., Vanderstichele, A., Benedetti Panici, P., Mueller, M., Ruscito, I., Zimmer, J., Woopen, H.

Volltext

PARP Inhibitors for Recurrent Ovarian Carcinoma: Current Treatment Options and Future Perspectives von Sehouli, J., Braicu, E. I., Chekerov, R.

Volltext

Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer von Hofstetter, G, Berger, A, Schuster, E, Wolf, A, Hager, G, Vergote, I, Cadron, I, Sehouli, J, Braicu, E I, Mahner, S, Speiser, P, Marth, C, Zeimet, A G, Ulmer, H, Zeillinger, R, Concin, N

Volltext

Clinical experience of young patients with small cell ovarian carcinoma of the hypercalcemic type (OSCCHT) von Woopen, H, Sehouli, J, Pietzner, K, Darb-Esfahani, S, Braicu, E.I, Fotopoulou, C

Volltext

Delta 133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer von Hofstetter, G, Berger, A, Schuster, E, Wolf, A, Hager, G, Vergote, I, Cadron, I, Sehouli, J, Braicu, E I, Mahner, S, Speiser, P, Marth, C, Zeimet, A G, Ulmer, H, Zeillinger, R, Concin, N

Volltext

Role of serum concentration of VEGFR1 and TIMP2 on clinical outcome in primary cervical cancer: Results of a companion protocol of the randomized, NOGGO–AGO phase III adjuvant tria... von Braicu, E.I., Fotopoulou, C., Chekerov, R., Richter, R., Blohmer, J., Kümmel, S., Stamatian, F., Yalcinkaya, I., Mentze, M., Lichtenegger, W., Sehouli, J.

Volltext

Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer von Mustea, A., Pirvulescu, C., Könsgen, D., Braicu, E.I., Yuan, S., Sun, P., Lichtenegger, W., Sehouli, J.

Volltext